BS
PRAH

Boenning & Scattergood’s PRA Health Sciences, Inc. PRAH Stock Holding History

Boenning & Scattergood’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,371
Closed -$227K – 395
2021
Q2 		$227K Hold
1,371
– – 0.04% 345
2021
Q1 		$210K Buy
+1,371
New +$186K 0.04% 340

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Boenning & Scattergood's PRAH Position: Q3 2021 in Review

Boenning & Scattergood sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,371 shares — an estimated $227K sold.

Boenning & Scattergood first reported a position in PRAH in Q1 2021 and held it in 2 quarters. The position peaked at $227K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Boenning & Scattergood reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Boenning & Scattergood sold 1,371 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $227K.
  • Boenning & Scattergood first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 2 quarters.
  • Boenning & Scattergood's PRA Health Sciences, Inc. position peaked at $227K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Boenning & Scattergood's 13F filing for Q3 2021, filed 21 Oct 2021.